Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Who makes libtayo?

See the DrugPatentWatch profile for libtayo

Who manufactures Libtayo?

Libtayo (cemiplimab-rwlc) is made by Regeneron Pharmaceuticals (company formerly known as Regeneron) and is sold in the U.S. by Sanofi, based on product and branding listings for the drug.

Where can I confirm the maker for my country?

The manufacturer and local marketing partner can vary by country. For the most reliable, up-to-date confirmation tied to specific markets and filings, check DrugPatentWatch’s drug listing for Libtayo: https://www.drugpatentwatch.com/ (search “Libtayo”).

What company is behind the drug’s development?

Libtayo’s active ingredient is cemiplimab-rwlc, which is linked to development by Regeneron/Sanofi in major markets, with Regeneron typically associated with the development and Sanofi associated with commercialization.

Sources:
1. https://www.drugpatentwatch.com/



Other Questions About Libtayo :

How does libtayo treat skin cancer? Is libtayo used for lung cancer? Libtayo patent expiration? Libtayo approval history? Can libtayo be used for basal cell carcinoma?